
This article analyzes gaps in US biosimilar development, quantifies market opportunities, and proposes policy and economic solutions to improve cost savings and patient access.
The American Journal of Managed Care
over 30 years ago
Job-Related Stress and the Quality of Pharmacists' Work Lifeover 30 years ago
The Professionalism of Pharmacy in a Managed Care Settingover 30 years ago
Management of the Menopausal Womanover 30 years ago
Any Willing IPA: Shaping the Market Through Legislation